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The role of veterinarian in the monitoring programs of mastitis 
control 
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Abstract. Mastitis is the most common and the most expensive disease of dairy cows. It is 
followed by a large number of direct and indirect costs that burden the farm's budget and lead 
to major economic and health losses. The veterinarian at the farm plays a key role in 
implementing a protocol of biosecurity measures, a protocol of control, therapy, and the 
suppression of clinical and subclinical mastitis. In order to successfully implement these 
measures, a good communication between a veterinarian and a farm staff who performs 
milking procedures is necessary in order to detect and treat all cases of mastitis in time. 
E-mail: maletic@vet.bg.ac.rs  
1. Introduction
It is well known that mammary gland diseases can be controlled by preventing the emergence of new 
infections and by eliminating existing sources of infection through a "five-point plan": 
‐ The udder disinfection  before and after milking, 
‐ All-encompassing dry off with antibiotics, 
‐ Adequate treatment of clinical mastitis, 
‐ Exclusion of cows with chronical disease, 
‐ Correct milking equipment. 
This approach proved to be very effective in the control of contagious mastitis [1]. 
Programs with the aim at improving the quality of milk are focused on the prevention of mastitis 
caused by agents from the environment of the animal, reduced use of antibiotics, etc. Veterinarian as a 
part of the chain of control of the health of herd, implements and controls the implementation of 
procedures for detection and identification of animals suspected on subclinical and clinical forms of 
mastitis in the herd. [2] Successful control of mastitis depends on the speed of detection, accurate 
diagnosis, selection of the best option for the treatment and introduction of preventive measures in 
order to reduce the exposure of cows to a specific pathogen [3]. An important role in the early 
detection of disorders of secretion of the mammary gland has the staff involved in the milking as they 
carry out on-the-spot checks on a dark media. Also, in monitoring the health of the udder, an important 
role has the good keeping of records of each cow in lactation. 
At the beginning of the introduction of the system of records and identification of cows on the 
farm, the veterinarian must be sure that he can answer the following questions: 
What is the incidence of clinical mastitis? How clearly are the symptoms of inflammation? Which is 
the most common cause of clinical and subclinical mastitis on a given farm? What are the most 
common protocols for treating these conditions? How many days is milk discarded due to ab 
treatment? How many percent of cows in lactation have less than 4 active mammary complexes? 
Which percentage of cows with problems of the mammary disease are excluded from production or 
died during one year? [4]  
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1.1 Monitoring of subclinical mastitis 
It is known that for control any subclinical disease it isimportant to have a clear understanding of 
prevalence and a mechanism to monitor incidence. Prevalence of mastitis depends on incidence, 
development of new subclinical cases, and duration. In some herds, the prevalence of mastitis can be 
small due to the existence of a chronic infection by infectious pathogens, while in other prevalence 
mastitis are high due to the existence of certain environmental factors that lead to the occurrence of 
acute mastitis. Very important moment in monitoring subclinical mastitis is to ensure that SCC values 
are routinely obtained from all cows on a regular basis. So that a cow with SCC values>200 000 
cells/ml are considering to have subclinical mastitis [4]. 
Expiriences say that for assessments of subclinical mastitis, the veterinarians should start with the 
following questions: What is the prevalence of subclinical mastitis based on SCC? What is the 
incidence of subclinical mastitis based on SCC? What are the most common bacteria recovered from 
cows with SCC values >200 000 cells/ml? How many subclinical cases persist more than 2 months? 
Prevalence of subclinical mastitis by days in milk and parity? How many cows have subclinical 
mastitis at the first test and the last test? [4]  
It is very important to monitor the SCC monthly at the herd level and the cow level. At the herd 
level, monthly monitoring of SCC could be very useful diagnostic tool for determining cows with 
subclinical mastitis. High prevalence of subclinical mastitis has the herd that has problems with 
enviromental mastitis pathogens, and veterinarian should investigate housing conditions, udder 
hygiene and management of dry and periparturient cows. In the cases where contagiuos mastitis is a 
problem, prevalence increase as lactation progresses  and as cow age because of more opportunities 
for exposure to infected milk. If we suspect on contagious mastitis, we should investigate the 
transmission of mastitis pathogens during milking. The existence of a large number of cows with 
chronically increased SCC, indicates that cows are infected with host adapted pathogens transmitted in 
a contagious manner. At the cow level, it is helful to look at the list of individual cows sorted by SCC 
to identify cows that require individual therapy. Also, it is helful to use of a rapid cowside quarter 
level SCC test [5].  
 
2. The treatment of mastitis 
The success of the treatment of mastitis depends on a number of factors, such as accurate diagnosis, 
proper antibiotic selection [6], early onset therapy, udder physiology and pathology, supportive 
therapies and elimination of predisposing factors [7], as well as factors of pathogenicity of the 
microorganism itself. 
The goal of antibiotic therapy is to destroy pathogenic microorganisms without damaging tissue of 
the mammary gland. Therapy of subclinical mastitis is not indicated except in cases where the 
causative agents of mastitis Staphylococcus aureus or Streptococcus agalactie. Therapy is then 
administered immediately after the diagnosis is made and should not wait the dry moment. The 
general principle of subacute mastitis therapy involves intramammary application of the preparation 
four times during 12 hours for fast-absorbed medicines or three times during 24 h for drugs that are 
slowly absorbed. Treatment should be continued at least 24 hours after clinical symptoms stop [9]. In 
peracute and acute mastitis, intramammary therapy is administered 3-5 days, twice a day, and 
depending on the severity of the clinical symptoms of the disease, antibiotics can be administered and 
parenterally with compulsory supportive therapy [9]. 
Four large groups of factors can lead to the failure of the treatment of mastitis: 
‐ Management and iatrogenic factors 
‐ Factors related to the microorganisms themselves 
‐ Factors related to the application of the drug and damaging the mammary gland 
‐ Factors related to the choice and method of application of the drug 
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Many management failures as well as iatrogenic factors can cause failure in therapy. The literature 
states the following factors: incorrect diagnosis [incorrectly take samples for microbiological analysis, 
some microorganisms require special conditions for cultivation and cannot be isolated in standard 
cultivation], delayed start of therapy, inadequate supportive therapy, duration of treatment, inadequate 
dose of the drug, improper use of the drug, introduction of new intramammary infections of the over-
ester injectors, super infections, reinfection, as well as completely clinical but not microbiological cure 
[7,11,12]. 
A large number of different drug-related factors can lead to failure of therapy [7, 8, 12], such as: 
inadequate drug choice, short drug half-life, inadequate concentration of the drug locally in the 
mammary tissue, adverse effects of the drug, low level of pharmacokinetic utilization, poor drug 
resorption through blood-milk barrier, high degree of binding of milk and serum proteins and 
combination of mzcocide and mycostatic antimicrobial agents [7]. 
 
3. Preventing the emergence of antibiotic residues in milk 
Wrong and inadequate antibiotic therapy in the treatment of mastitis entails a large number of 
potential risks. Antibiotic residues adversely affect fermentation processes that are unavoidable in the 
production of cheese and yogurt. Residue of antibiotics can cause allergy in susceptible individuals, as 
well as the occurrence of resistance in some pathogenic microorganisms. The main causes of the 
persistence of antibiotic residues in milk are the administration of not recommended drugs whose 
pharmacokinetics is not completely established, excess dose administration, lack of compliance with 
the milk discard period in the case of treated animals, identification errors of treated animals, and 
confusion of milk after milking treated animals [13,14]. Also, the big problem on smaller farms is the 
self-inducing and inefficient application of the injector by irresponsible farmers. Special attention 
should be paid to veterinarians to monitor the antibiotic withdrawal period due to other therapeutic 
indications. Such cows must be separately labeled and separated from each healthy mature cow. Milk 
treated cows must be destroyed in a special way, and in any case, such calves are fed calves or used 
for other purposes.  
In July 2017, Codex Alimentarius Commission prescribed new legislation “Maximum residue 
limits [MRLs] and risk management recommendations [RMRs] for residues of veterinary drugs in 
foods” [15]. But in Serbia, according to legislation on the quality of raw milk, the minimum allowed 
concentrations of residues in milk are not clearly defined [16]. 
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